DJIA 18,214.42 -10.15 -0.06%
NASDAQ 4,987.89 20.75 0.42%
S&P 500 2,110.74 -3.12 -0.15%
market minute promo

419.87 -3.17 (-0.75%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

REGN $419.87 -0.75%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $425.00
Previous Close $423.04
Daily Range $416.20 - $427.93
52-Week Range $269.50 - $437.64
Market Cap $43.1B
P/E Ratio 137.80
Dividend (Yield) $0.00 (0.0%)
Volume 691,046
Average Daily Volume 838,637
Current FY EPS $7.79

Sector

Healthcare

Industry

Drug Makers

Regeneron Pharmaceuticals, Inc. (REGN) Description

The Company is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions. Website: http://www.regeneron.com/

News & Commentary

Billions on the Line in the Next Drug Pricing War

Could approval of two new cholesterol drugs lead to another high stakes pricing war?

Biotech Stock Roundup: Pharmacyclics Up on Buyout Rumors, Celgene Drug Label Expanded - Analyst B

Biotech Stock Roundup: Pharmacyclics Up on Buyout Rumors, Celgene Drug Label Expanded - Analyst Blog

Can These Three BioTech Companies Make It Big?

Comparing America's Next 3 Biotechnology Companies

Regeneron's Eylea Tops Diabetic Macular Edema Study - Analyst Blog

Thursday's ETF Movers: PBE, ICF

Nasdaq 100 Movers: VIP, PCLN

Regeneron Beats on Q4 Earnings Driven by Eylea Sales (revised) - Analyst Blog

Stock Market News for February 18, 2015 - Market News

'Mad Money' Lightning Round: Buy, Buy, Buy Terrific Lowe's

See More REGN News...

REGN's Top Competitors

REGN $419.87 (-0.75%)
Current stock: REGN
AMGN $158.97 (0.56%)
Current stock: AMGN
GILD $104.19 (-0.23%)
Current stock: GILD
BIIB $410.10 (0.28%)
Current stock: BIIB